Tardive Dyskinesia TD as a neurological disorder resulting in involuntary repetitive movement disorder as a disease of brain Neurology due to dopamine problems. What have studies said the role vitamin ...

—With the support of a leading scientific organization, a group of U.S.-based researchers designed 3 rounds of questionnaires to decide which term neurologists and psychiatrists should adopt going ...

Tardive dyskinesia is a common side effect caused by antipsychotic use. It is a neurological disorder characterized by involuntary, repetitive movements, often involving the face, mouth, tongue, and ...

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person’s underlying mental ...

Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps. Less than half of patients diagnosed with tardive dyskinesia in ...

If you or someone you know has been diagnosed with Parkinson’s disease, there is a good chance that they will receive the standard combination of the drugs levodopa and carbidopa. The treatment is ...

—The exact pathology of tardive dyskinesia is still unclear, but the potential genetic factors these investigators have identified may enhance the understanding, treatment, and prevention of this ...

Currently there are two FDA approved treatment options for tardive dyskinesia. There are two medications that are VMAT2 inhibitors. These are valbenazine (Ingrezza) and deutetrabenazine (Austedo) made ...

So one of the trials that I'm interested in watching is an extension trial of the IMPACT-TD registry that's currently going on and being done by Teva Pharmaceuticals, who are the manufacturers of ...

Tracking your tardive dyskinesia symptoms provides insight into what’s going on. Tardive dyskinesia (TD) is a movement disorder that causes certain uncontrollable movements in different parts of the ...

The findings of this study align with prior research that suggests lower effective doses of clozapine are required for patients of Indian descent compared to Western populations. Switching patients of ...